Cargando…
O7.2. BREAKTHROUGH ON ANTIPSYCHOTIC MAINTENANCE MEDICATION IN A CLINICAL COHORT
BACKGROUND: Antipsychotic drugs are effective in reducing the severity of psychotic symptoms both in the short and long term, and in reducing risk of relapse. However, some patients may develop a relapse of their psychotic symptoms despite continued antipsychotic treatment. Arguably, this phenomenon...
Autores principales: | Rubio, Jose, Correll, Christoph, Malhotra, Anil, John, Majnu, Kane, John |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5887801/ http://dx.doi.org/10.1093/schbul/sby015.231 |
Ejemplares similares
-
T234. BREAKTHROUGH ON ANTIPSYCHOTIC MAINTENANCE MEDICATION: A STUDY-LEVEL META-ANALYSIS AND META-REGRESSION ANALYSIS
por: Rubio, Jose, et al.
Publicado: (2018) -
Psychosis breakthrough on antipsychotic maintenance medication (BAMM): what can we learn?
por: Rubio, Jose M., et al.
Publicado: (2017) -
Antipsychotic monotherapy and polypharmacy in the naturalistic treatment of schizophrenia with atypical antipsychotics
por: Faries, Douglas, et al.
Publicado: (2005) -
T232. EFFICACY AND SAFETY OF ANTIDEPRESSANT AUGMENTATION OF ANTIPSYCHOTICS IN SCHIZOPHRENIA
por: Galling, Britta, et al.
Publicado: (2018) -
Controversies Surrounding the Use of Long-Acting Injectable Antipsychotic Medications for the Treatment of Patients with Schizophrenia
por: Kane, John M., et al.
Publicado: (2021)